These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exacerbation of premenstrual asthma caused by an oral contraceptive. Derimanov GS; Oppenheimer J Ann Allergy Asthma Immunol; 1998 Sep; 81(3):243-6. PubMed ID: 9759802 [TBL] [Abstract][Full Text] [Related]
5. [Premenstrual complaints. Influence of oral contraceptives (author's transl)]. Andersch B; Hahn L Contracept Fertil Sex (Paris); 1982 Oct; 10(10):659-64. PubMed ID: 12338448 [TBL] [Abstract][Full Text] [Related]
6. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice]. Svojanovská K Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928 [TBL] [Abstract][Full Text] [Related]
7. The psychical and sexual adaptation of oral contraceptive users. IPPF Med Bull; 1969 Mar; 3(1):1-2. PubMed ID: 12305529 [TBL] [Abstract][Full Text] [Related]
8. Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes. Freeman EW; Rickels K; Sondheimer SJ; Polansky M J Clin Psychopharmacol; 2001 Oct; 21(5):540-2. PubMed ID: 11593086 [No Abstract] [Full Text] [Related]
9. Factor structure of the Menstrual Symptom Questionnaire: relationship to oral contraceptives, neuroticism and life stress. Stephenson LA; Denney DR; Aberger EW Behav Res Ther; 1983; 21(2):129-35. PubMed ID: 6682315 [No Abstract] [Full Text] [Related]
10. Use of norethindrone .35 mg in disorders of the menstrual cycle. Ferrari AN; Berge I; Rosito CL; Russowsky M; Barbisan AB; Roeche T J Bras Ginecol; 1970 May; 69(5):299-306. PubMed ID: 12259292 [TBL] [Abstract][Full Text] [Related]
11. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
13. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
14. Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being. Mansour D Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():35-41; discussion 42-3. PubMed ID: 12659405 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. Megivern D J Womens Health Gend Based Med; 2002 Mar; 11(2):95-6. PubMed ID: 11975855 [No Abstract] [Full Text] [Related]
17. Depressive symptoms and oral contraceptives. Herzberg BN; Johnson AL; Brown S Br Med J; 1970 Oct; 4(5728):142-5. PubMed ID: 5475818 [TBL] [Abstract][Full Text] [Related]
18. Changes in psychological symptoms in women taking oral contraceptives. Herzberg B; Coppen A Br J Psychiatry; 1970 Feb; 116(531):161-3. PubMed ID: 5461253 [No Abstract] [Full Text] [Related]